← Latest Filings
H

Hite Christopher

EVP & Chairman, Partnering

Open-market buys
0
$0 total
Open-market sells
9
$27.4M total
Tracking since
Jun 2026
Open-market sale — $231K
Royalty Pharma plc · Sep 22, 2026
Open-market sale — $5.6M
Royalty Pharma plc · Sep 22, 2026
Open-market trades from the last two years.
270,401 Class A Ordinary Shares in RPRX
Held indirectly (By SCH Investment Partners LLC) · as of 2026-09-22
38,300 Stock Option (right to buy) in KLRA
Held directly · as of 2026-04-16
Royalty Pharma plc
CIK 0001802768
Vera Therapeutics, Inc.
CIK 0001831828